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Background: Morinda citrifolia (Noni) is an edible plant with wide range of medicinal uses. It occurs exclusively in
tropical climate zone from India through Southeast Asia and Australia to Eastern Polynesia and Hawaii. The
objective of this study was to explore the possible mode(s) of action for its antispasmodic, vasodilator and cardio-
suppressant effects to rationalize its medicinal use in gut and cardiovascular disorders.
Methods: Isolated tissue preparations such as, rabbit jejunum, rat and rabbit aorta and guinea pig atria were used
to test the antispasmodic and cardiovascular relaxant effects and the possible mode of action(s) of the 70%
aqueous-ethanolic extract of Morinda citrifolia roots (Mc.Cr).
Results: The Mc.Cr produced a concentration-dependent relaxation of spontaneous and high K
+ induced
contractions in isolated rabbit jejunum preparations. It also caused right ward shift in the concentration response
curves of Ca
++, similar to that of verapamil. In guinea-pig right atria, Mc.Cr caused inhibition of both atrial force
and rate of spontaneous contractions. In rabbit thoracic aortic preparations, Mc.Cr also suppressed contractions
induced by phenylephrine (1.0 μM) in normal- Ca
++ and Ca
++-free Kerb’s solutions and by high K
+, similar to that
of verapamil. In rat thoracic aortic preparations, Mc.Cr also relaxed the phenylephrine (1.0 μM)-induced
contractions. The vasodilatory responses were not altered in the presence of L-NAME (0.1 mM) or atropine (1.0 μM)
and removal of endothelium.
Conclusions: These results suggest that the spasmolytic and vasodilator effects of Mc.Cr root extract are mediated
possibly through blockade of voltage-dependent calcium channels and release of intracellular calcium, which may
explain the medicinal use of Morinda citrifolia in diarrhea and hypertension. However, more detailed studies are
required to assess the safety and efficacy of this plant.
Background
Morinda citrifolia Linn (Fam. Rubiaceae) is commonly
known as Noni or Indian mulberry. It occurs from India
through Southeast Asia and Australia to Eastern Polyne-
sia and Hawaii [1]. It is an edible plant and has been
used in herbal remedies to treat various common dis-
eases and to maintain overall good health [2]. Different
parts of the plant including stem, bark, root, leaf, and
fruits have been used in the system of traditional medi-
cine to treat a broad range of diseases, including hyper-
tension [3], atherosclerosis [2], colic [4] and diarrhea [5].
Morinda citrifolia, has been reported to possess
antithrombotic [6], antioxidant [7], analgesic and antiin-
flammatory [8] and xanthine oxidase inhibitory [9] activ-
ities There are also preliminary studies reporting its
blood pressure lowering[10] and vasodilatory [11] prop-
erties. However, the possible modes of action(s) of car-
diovascular activities are lacking. The current study
* Correspondence: anwar.gilani@aku.edu
† Contributed equally
1Natural Product Research Division, Department of Biological and Biomedical
Sciences, Aga Khan University Medical College, stadium road, Karachi-74800,
Pakistan
Gilani et al. BMC Complementary and Alternative Medicine 2010, 10:2
http://www.biomedcentral.com/1472-6882/10/2
© 2010 Gilani et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.reports possible mode of action(s) of antihypertensive,
vasodilator and antispasmodic activities.
Methods
Plant material
The vacuum dried 70% aqueous-ethanolic extract of
Morinda citrifolia root was obtained from the Sami
Labs Limited 19/1, 19/2, 1st Main II Phase, Peenya, Pee-
nya Industrial Area Bangalor-560 058, India. The extract
was prepared by following procedure as described by
the manufacturer. Dried roots of Morinda citrifolia were
procured from a reputed herb supplier in Southern
India. The roots were chopped and ground by hammer
mill and passed through 20 mesh screen. The powder
(12 Kg) was extracted with 70% ethanol (48 L) at 70°C
for 3 hours and filtered. The procedure repeated 2 more
times and all filtrates combined and evaporated under
vacuum. The dried extract was packed in polythene
bags with nitrogen purge. The yield of the extract was
3.75%.
A sample of the extract was deposited at the herbar-
ium of department of biological and biomedical
sciences, Aga Khan University Karachi, Pakistan with
voucher # MC-RT-02-08-82.
Phytochemical screening
The Morinda citrifolia root extract was tested for the
presence of various phytochemical classes of compounds
such as alkaloids, phenolic compounds, strerols, flavo-
noids, tannins, coumarins and anthraquinones using
method described by Khan and Gilani [12].
Drugs and standards
The following reference chemicals were obtained from
the source specified acetylcholine chloride, atropine sul-
fate, Nù-nitro-L-arginine methyl ester (L-NAME), phe-
nylephrine hydrochloride, and verapamil hydrochloride
(Sigma Chemical Company, ST Louis, MO). The follow-
ing chemicals were used to make the physiological salts
solution: potassium chloride (Sigma Chemicals Co.), cal-
cium chloride, glucose, magnesium chloride, magnesium
sulfate, potassium dihydrogen phosphate, sodium bicar-
bonate, sodium dihydrogen phosphate (Merck, Darm-
stadt, Germany) and sodium chloride (BDH Laboratory
Supplies, Poole, England). All chemicals used were of
the analytical grade available and dissolved in distilled
water.
Animals
Rabbits (1000-1300 g), guinea-pigs (500-600 g), Sprague-
Dawley rats (180-220 g) and mice (20-25) of either sex
were obtained from the animal house of the Aga Khan
University, Karachi. The animals were housed in con-
stant room temperature (23-25°C) and given free access
to food and water. Rabbits and guinea-pigs were starved
for 24 hrs prior to experiment and sacrificed by cervical
dislocation. Experiments performed complied with the
rulings of the Institute of Laboratory Animal Resources,
Commission on Life Sciences [13] and approved by the
Ethical Committee of the Aga Khan University, Karachi.
Isolated tissue preparations
Rabbit jejunum
The spasmolytic activity and possible mode of action of
the plant materials were studied by using isolated rabbit
jejunum as described previously [14]. Each segment of
about 2 cm length was suspended in a 10 ml tissue bath
containing Tyrode’s solution, maintained at 37°C and
aerated with a mixture of 95% oxygen and 5% carbon
dioxide (carbogen). The tissues were allowed to equili-
brate for at least 30 min at preload of 1 g. Tension
changes in the tissue were recorded via a force displace-
ment transducer (model FT-03) coupled with Bridge
Amp and PowerLab 4/25 data acquisition system con-
nected to computer running chart 5.3 software (ADIn-
strument, Sydney, Australia). The smooth muscles
relaxant action of test materials was observed by admin-
istration of test drugs in a cumulative fashion directly
without the use of an agonist.
To assess whether the spasmolytic activity of the test
substance was through calcium channel blockade (CCB),
high K
+ (80 mM), as KCl, was used to depolarize the
preparations [15]. The K
+ (80 mM) was added to the
tissue bath, which produced a sustained contraction.
The test materials were then added in a cumulative
fashion to obtain concentration-dependent inhibitory
responses. To confirm the Ca
++ antagonist property of
the test substance, the tissue was allowed to stabilize in
normal Tyrode’s solution, which was then replaced with
Ca
++-free Tyrode’s solution containing EDTA (0.1 mM)
f o r3 0m i n u t e si no r d e rt or e m o v eC a
++ from the tis-
sues. This solution was further replaced with K
+-rich
and Ca
++-free Tyrode’s solution. Following an incuba-
tion period of 30 min, control concentration-response
curves (CRCs) of Ca
++ were obtained. When the control
Ca
++ CRCs were found super-imposable (usually after
two cycles), the tissue was pre-treated with the crude
extract for 60 min. The CRCs of Ca
++ were recon-
structed in the presence of different concentrations of
the extract.
Rabbit and rat aortic preparations
Rabbit and rat aorte are used commonly to study the
possible vasodilator effects of test drugs. Descending
thoracic aorta, isolated from either rabbits or rat were
obtained and cut into 2-3-mm wide rings that were
individually mounted in 10 ml tissue bath containing
Kerb’s solutions maintained at 37°C and aerated with
carbogen gas. A resting tension of 2 g was applied to
each tissue changes in tension were recorded through a
force displacement transducer (Fort-100, WPI, Hertford-
shire, UK) couple to a bridge amplifier (Transbridge
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system (ADInstrument, Sydney, Australia). An equili-
brium period of one hour was allowed before experi-
mentation with drug as described previously [16].
Rabbit aorta was used primarily to evaluate the effect
of extract on K
+- and PE-induced contraction to test if
the extract has effect on voltage-operated and/or recep-
tor-operated channels and on release of calcium from
intracellular stores. Rat aorta was primarily used to
further evaluate if the vasodilation caused by extract was
endothelial-dependent or -independent [17]. Further-
more, using different species are helpful to see the spe-
cies selective effects of any extract as described
previously [18].
Guinea-pig atria
Right atria isolated from guinea-pig killed by cervical
dislocation were mounted in 20 ml tissue baths contain-
ing normal Kreb’s solution maintained at 32°C and aera-
ted with carbogen, as described previously [19]. The
tissues were allowed to beat spontaneously under the
resting tension of 1 g. Tension changes in the tissue
were recorded through force-displacement transducer
(model FT-03) using a grass Model 7 Polygraph. After
equilibrium period of 30 minutes, control responses of
isoprenaline (1 μM) and acetylcholine (1 μM) were
obtained at least in duplicate. The test substances were
then added cumulatively and the effect on force and
rate of contractions was determined as percent of the
pre-treated control.
Acute toxicity test
Animal were divided in groups of 5 mice each. The test
was performed using increasing doses of the plant
extracts (3, 5, 10 g/kg), given orally, in 10 ml/kg volume
to different groups serving as test groups. Another
group of mice was administered saline (10 ml/kg, p.o.)
served as negative control. The mice were allowed food
and water ad libitum during a 24 hr test period and
kept under regular observation for gross behavioural
changes and mortality.
Data analysis and statistics
All the data expressed as mean ± SEM and the median
effective concentrations (EC50) values are given as geo-
metric mean with 95% confidence intervals (CI). CRCs
were analyzed by nonlinear regression (Sigmoidal dose-
response curve variable slop). While One-way Analysis
of Variance (one-way ANOVA) followed by Tukey’s
post-test was used to determine the significant differ-
ence in various doses, P value < 0.05 (P < 0.05) were
considered statistically significant. All the graphs, calcu-
lation and statistical analyses were performed using
GraphPad Prism software version 4.00 for Windows,




Qualitative phytochemical study that the Morinda citri-
folia root extract show the presence of saponins, flavo-
noids, anthraquinine coumarines, sterols and phenolic
compounds.
Effects on rabbit jejunum
In isolated rabbit jejunum preparation, the root extract
of Morinda citrifolia (Mc.Cr), inhibited the spontaneous
contractions in a concentration-dependent manner with
EC50 value (95% CI;) of 0.30 mg/ml (0.24 - 0.39; n = 4),
similar to that of verapamil as shown in Figure 1. When
tested against high K
+ (80 mM)-induced contractions,
Mc.Cr caused relaxation with EC50 value of 0.06 mg/ml
(0.05-0.08; n = 4) as shown in Figure 2A. Mc.Cr caused
relaxation of K
+ (80 mM)-induced contractions at lower
concentration compared to that of spontaneous contrac-
tions. Similar pattern was seen with verapamil, which
produced relaxation of K
+ (80 mM)-induced contrac-
tions with EC50 value of 0.04 μM/ml (0.03-0.04; n = 4)
at lower concentration than that of spontaneous con-
tractions in rabbit jejunum with EC50 value of 0.23 μM/
ml (0.19-0.27; n = 4) as shown in Figure 2B. Pre-treat-
ment of the tissues with Mc.Cr (0.03 or 0.1 mg/ml; n =
4) showed rightward shift in the Ca
++ concentration
response curves similar to that of verapamil as shown in
Figure 3.
Effect on thoracic aorta
In endothelium-intact rat aortic preparations precon-
tracted with phenylepherine (PE 1 μM), Mc.Cr caused
inhibition of induced contractions dose-dependently
with EC50 value of 1.23 mg/ml (0.98-1.55; n = 4). The
vasorelaxant activity was not altered in the presence of
L-NAME (0.1 mM) with resulting EC50 value of 1.33
mg/ml (0.88-2.01; n = 4) or atropine (1.0 μM) with EC50
value of 1.30 mg/ml (0.85-1.97; n = 4), similarly removal
of endothelium did not alter the potency. These effects
were similar to those observed with verapamil as show
in Figure 4.
In the rabbit aorta, Mc.Cr also caused concentration-
dependent vasodilatation against PE (1 μM) and high K
+
(80 mM)-induced contractions, with EC50 value of 1.68
mg/ml (1.30-2.19; n = 4) and 0.76 mg/ml (0.69-0.84; n =
4), similar to that of verapamil as shown in Figure 5.
Mc.Cr was also tested in increasing doses against PE (1
μM) peak responses as show in Figure 6, where it inhib-
ited the PE (1 μM) peaks in normal-Ca
++ and Ca
++ free
Kerb’s solution dose-dependently (0.01-1.0 mg/ml, p <
0.001; n = 4), similar to that of verapamil (0.03-0.3 μM,
n = 4) as shown in Figure 7.
Effect on isolated guinea-pig atria
In isolated spontaneously beating guinea-pig atrial pre-
parations, Mc.Cr exhibited concentration-dependent
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contractions with EC50 value of 2.52 mg/ml (2.01-3.15;
n = 4) and 2.69 mg/ml (2.05-3.53; n = 4) respectively.
Similar effects of verapamil were seen in this prepara-
tion as shown in Figure 8. The inhibitory effects on
heart were at relatively higher concentrations than those
on smooth muscle preparations (P < 0.001).
Acute toxicity
In mice, Mc.Cr did not cause any mortality and changes
in gross behaviour up to the dose of 10 g/Kg as com-
pared to control group.
Discussion
The 70% aqueous-ethanolic extract of the Morinda citri-
folia roots (Mc.Cr) caused a concentration-dependent
inhibition of spontaneous contractions in isolated rabbit
jejunum preparations, thus showing antispasmodic
action. In earlier studies, we observed that the spasmoly-
tic effect of medicinal plants is usually mediated through
calcium channel blockade [20,21]. To assess whether the
spasmolytic activity of this plant was also mediated
through Ca
++ channel blockade (CCB), high K
+ (80
mM), as KCl, was used to depolarize the preparations
Figure 1 Typical tracing showing inhibitory effect of crude extract of Morinda citrifolia (Mc.Cr) and verapamil on the spontaneous
contractions in isolated rabbit jejunum preparations.
Figure 2 Inhibitory effect of the (A) Mc.Cr and (B) verapamil on spontaneous and high K
+-induced contractions in isolated rabbit
jejunum preparations
###P < 0.001; shows a comparison of concentration-dependent effects (specified effect compared with the
effect of preceding dose) on spontaneous contractions, whereas **P < 0.01; ***P < 0.001; show comparisons of relaxant effects on K
+
(80 mM)-induced contractions.
Gilani et al. BMC Complementary and Alternative Medicine 2010, 10:2
http://www.biomedcentral.com/1472-6882/10/2
Page 4 of 9Figure 3 Concentration-response curves of Ca
++ in the absence and presence of the increasing concentrations of Mc.Cr (A) and
verapamil (B), constructed in Ca
++-free and K
+-rich (80 mM) Tyrode’s solution in isolated rabbit jejunum.***P < 0.001; compared to the
respective control.
Figure 4 Concentration-response curves showing the vasodilator effect of Mc.Cr (A) and verapamil (B) in the absence and presence of
the Nω-nitro-l-arginine methyl ester (L-NAME, 0.1 mM) and atropine (1 μM) and on phenylephrine (PE 1 μM) induced contractions in
isolated endothelium-intact and denude rat aorta preparations. **P < 0.01; ***P < 0.001; shows a comparison of concentration-dependent
effects(specified effect compared with the effect of preceding dose) on endothelial intact rat aorta, whereas,
ωωωP < 0.001; shows a comparison
of concentration-dependent effect on endothelial denuded rat aorta and
æææP < 0.001; shows a comparison of concentration-dependent effect
on L-NAME with endothelial intact rat aorta,
###P < 0.001; shows a comparison of concentration-dependent effect on atropine pre-treatment
with endothelial intact rat aorta.
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+ (> 30 mM) is known to cause smooth
muscle contractions through opening of voltage-depen-
dent L-type Ca
++ channels, thus allowing influx of extra-
cellular Ca
++ causing a contractile effect [22] and a
substance causing inhibition of high K
+-induced con-
traction is considered as a blocker of Ca
++ influx [23].
Mc.Cr relaxed the high K
+ (80 mM)-induced contrac-
tions, similar to that caused by verapamil, a standard Ca
++ antagonist [24]. The presence of Ca
++ antagonist con-
stituent(s) was further confirmed when pre-treatment of
the tissue with Mc.Cr shifted the Ca
++ CRCs to the
right. Calcium antagonists form an important therapeu-
tic group and the common characteristic of these drugs
are their dose-dependent inhibition of slow entry of Ca
+
+ and their capacity for reversal of this effect by Ca
++
[24]. The spasmolytic activity of Mc.Cr mediated possi-
bly through Ca
++ antagonist effect explains its therapeu-
tic usefulness in hyperactive gut disorders, such as
abdominal colic and diarrhoea, as the CCB are known
to be useful in such disorders [25].
Blood pressure is the product of cardiac output and
peripheral resistance, increase in either or both can con-
tribute to the development of hypertension. Since Mor-
inda citrifolia is used in hypertension, the plant extract
was studied further for its possible mode of action in
isolated cardiovascular preparations. In guinea-pig right
atria, Mc.Cr caused suppression of the force and rate of
spontaneous contractions in a concentration-dependent
manner, similar to that caused by verapamil. In rat and
rabbit aortae, Mc.Cr also caused relaxation of contrac-
tions induced by either PE or high K
+, similar to that of
verapamil. In order to investigate if Mc.Cr also affects
intracellular stores, Mc.Cr was tested against PE-induced
contractions in Ca
++-free solution, where it caused con-
centration-dependent suppression of contractile
responses of PE, similar to those observed with verapa-
mil, indicating that the extract is inhibiting the release
of calcium from intracellular stores [17]. To investigate
involvement of other mechanisms, the rat aorta was
used. In this preparation, the vasodilatory response was
not altered by removal of endothelium and in the pre-
s e n c eo fe i t h e ra t r o p i n e( as t a n d a r dm u s c a r i n i ca n t a g o -
nist) [26] or L-NAME (a standard nitric oxide synthase
inhibitor) [27]. These finding suggest that the vasodila-
tory response of Mc.Cr is mediated through inhibition
of receptor and voltage operated calcium channels and
inhibition of release of calcium from intracellular stores.
However, release of vasoactive substances from endothe-
lium, or nitric oxide synthase or stimulation muscaric
receptors do not appear to play role in the vasodilaroy
activity of Mc.Cr.
Furthermore, the CCB effects of Mc.Cr in the gut or
vascular tissues were observed at lower concentrations
than the effect in cardiac tissue, which indicates selec-
tive effect of this plant in smooth muscle preparations.
This difference may be due to the heterogeneity of
Figure 5 Concentration-response curves showing the vasodilator effect of Mc.Cr (A) and verapamil (B) on phenylephrine (PE 1 μM)
and K
+ (80 mM) induced contractions in isolated rabbit aortic preparations.
#P < 0.05;
##P < 0.01;
###P < 0.001; shows a comparison of
concentration-dependent effect on phenylephrine (PE 1 μM) induced contraction.*P < 0.05;**P < 0.01; ***P < 0.001; show comparisons of
concentration dependent effects on K
+ (80 mM) induced contractions.
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exhibit selectivity for a specific organ system [28].
Therefore, studies at molecular and cellular level are
suggested to evaluate exact mechanism of action(s).
In acute toxicity studies Mc.Cr did not cause any mor-
tality upto 10 g/Kg dose, which is much higher than the
routinely used dose. However, more detailed subacute
and chronic toxicity studies are required to establish the
safety of this commonly used plant.
Conclusions
In summary, the findings suggest that Mc.Cr has anti-
spasmodic, vasodilator and cardiodepressant activities
which are mediated possibly through blockade of cal-
cium channels as well as release of calcium from intra-
cellular stores. These findings may explain the medicinal
use of Morinda citrifolia in abdominal colic, diarrhoea
and hypertension. However, more detailed studies are
required to establish the safety, efficacy and active con-
stituents of this plant.
Acknowledgements
This study was supported by the Pakistan Science Foundation through
research project # PSF/Res/S-AKU/BIO (377).
We also appreciate the supply of Morinda citrifolia extract as a gift from a M/
S Sami Labs Limited 19/1, 19/2, 1st Main II Phase, Peenya, Peenya Industrial
Area Bangalor-560 058, India.
We are thankful to Malik Hassan Mehmood for his technical guide and
support.
Author details
1Natural Product Research Division, Department of Biological and Biomedical
Sciences, Aga Khan University Medical College, stadium road, Karachi-74800,
Pakistan.
2Departments of Pharmacy and Biochemistry, University of
Balochistan, Sariab road, Quetta, Pakistan.
3King Saud University, Riyadh,
Kingdom of Saudi Arabia.
Figure 6 Typical tracing showing the increasing concentration-dependent suppression of (A) Mc.Cr and (B) verapamil on control
phenylephrine (PE 1 μM) peaks in the normal- Ca
++ and Ca
++-free Kerb’s solution.
Gilani et al. BMC Complementary and Alternative Medicine 2010, 10:2
http://www.biomedcentral.com/1472-6882/10/2
Page 7 of 9Authors’ contributions
AHG identified the plant, raised funds, supervised the work and refined the
manuscript for publication. SRM carried out the draft, experimental work,
data collection and evaluation, literature search and manuscript preparation.
JI and MY co-supervised the work and corrected the manuscript for
publication. NA helped in study design, analysis of data and preparing draft
manuscript. AK and NR helped in the experimental work, analysis of data
and preparing draft manuscript. All authors read and approved the final
manuscript for publication.
Competing interests
The authors declare that they have no competing interests.
Received: 11 June 2009
Accepted: 13 January 2010 Published: 13 January 2010
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isolated rabbit aorta preparations. ***P < 0.001; shows a comparison of dose dependent effect on phenylephrine (PE 1 μM) rabbit aorta.




###P < 0.001; show comparison of concentration-dependent effects on force while *P < 0.05;**P < 0.01; ***P < 0.001;
show comparison of concentration-dependent effects on rate of guinea-pig atria.
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